Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Randal W. Scott,PhDN/A1,185,1173.59%2012-07-10
Steven Shak,M.D.Chief Scientific Officer327,2070.99%2016-06-21
Joffre B. Baker,PhDN/A132,8460.4%2012-02-15
Dr. Fred E. Cohen,M.D.,D.Phil.N/A64,5200.2%2016-04-01
Kimberly J. PopovitsN/A58,7960.18%2016-02-15
G. Bradley ColeCOO35,4260.11%2016-06-09
Mr. James J. VaughnChief Commercial Officer32,0790.1%2016-06-06
Mr. Frederic PlaN/A25,618less than 0.1%2016-02-15
Mr. Dean L. SchornoN/A24,524less than 0.1%2014-06-10
Brook H. ByersN/A23,951less than 0.1%2010-12-09

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.850.5327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.1-2.735,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.92-7.532,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.6138-6.1634,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.01-4.7815,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$2856-7.531,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.31.85326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.08-7.524,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-19.426,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-18.2727,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-22.9924,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.04-11.4827,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.19-11.6912,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.66-11.6924,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.12-0.530,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.982.1730,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.12-5.9230,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.96-1.330,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.16-5.9529,658 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2015-04-13Sell3,000203,001$31.2893.84-17.2Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.76-14.9129,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-18.83Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-18.6629,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.58-13.26Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-17.4421,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-18.896,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-22.59Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-21.49Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-20.3621,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-25.62Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-26.7322,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-28.536,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.34-15.85Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.08-9.9822,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.46-13.15Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.42-13.9222,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.2-5.34312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.21-0.65Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.77-2.59Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.22-4.2522,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$27189-4.07312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.11-3.11312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.3-0.77Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.48-6.2324,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.78-5.0922,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.62-2.41Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.363.2323,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.75-1.33311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$2781-4.0722,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.52-8.67311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.28-6.722,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.58-7.115,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.66-5.41311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$2781-4.0724,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-17.8308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$3075-13.67Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.51-8.0618,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.98-12.41308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.7-15.58Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-22.1121,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-25.836,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-25.1Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-22.3621,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-17.4618,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.35-12.71308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$3075-13.67Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.88-13.5218,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-23.21313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-24.51Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-20.3818,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-21.2821,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-17.756,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-21.47318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-21.59Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-21.8721,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-21.8721,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-23.0519,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-26.69318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-25.17Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-23.417,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-23.417,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-22.2913,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-22.73323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-27.41Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-27.8117,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-28.37
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-28.9813,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-29.45
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-28.856,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-29.79
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-29.87
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-30.97,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-30.36327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-28.94
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-27.716,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-24.58
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-24.757,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-25.36Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-28.117,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-28.0412,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$3075-13.67Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.48-6.812,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.43-9.3512,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.58-6.77
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.4-7.937,087 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.96-9.06
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.5-8.82,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.53-7.99
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.08-7.614,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.54-9.986,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.5-7.517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.7-7.114,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.7-6.63333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.95-6.8Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$2884-7.517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.68-6.976,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.12-3.47288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.26-3.6836,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.7-3.86338,768 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.52-5.2288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.2-4.92Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.1-6.87288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$2884-7.517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.55-9.514,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-21.7Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-26.52343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-23.3517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-23.3311,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-25.5714,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-23.28348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-18.27Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-26.0214,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-26.422,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-25.98353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-25.4Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.23-15.0514,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-27.866,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-24.36358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-25.49Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-26.82Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-27.9614,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-22.11363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-22.36Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-22.36Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-22.78Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-23.7613,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-23.37367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-19.71
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-21.5926,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-23.55
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-24.34Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-23.1217,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.04-13.55
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.6-14.3Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.18-10.2913,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.69-8.96
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.42-8.196,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.65-7.27372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.95-6.8Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.98-7.4318,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.8-9.41Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.7-14.4613,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-13.9377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-13.87Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.35-13.87Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.4-13.9377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-16.6719,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-16.59Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.85-13.4913,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.74-13.98
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.09-13.98
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.09-13.98
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.1-13.12
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.37-13.12
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.01-13.12
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.19-10.87
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.6-10.87
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.71-10.87
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.5285-9.12Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.38-7.7
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.8-7.7
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.1-7.7
1,419,381 (Through Partnership)
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.7-7.96382,849 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.65-11.72
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.85-11.81
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.34-11.81
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.71-9.9420,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.76-9.9420,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.24-1.75
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.09-1.75
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.13-1.75
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.6-1.07Link
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.6-1.07Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.18-2.1514,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.02-5.856,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.1-1.97Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.1-2.7Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.7-3.14382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$2828-7.517,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.85-5.957,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.2-5.68Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.15-0.5387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.8-5.09Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.48-9.417,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.63-7.89
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.72-6.36
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.16-7.89
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.31-0.04
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.16-0.15
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.78-0.04
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.35-0.65392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.98-6.53
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.66-6.53
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.53-5.3
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.19-4.88
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.48-4.88
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.8-4.92Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.52-3.32
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.5-2.637,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.74-0.15
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.49-0.15
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.945.8
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1617.36,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.819.03392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.613.45Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5516.097,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.224.46Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.217.37,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.112.51392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.85.97Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.152.537,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.152.537,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.9-2.086,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.05-6.19392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.2-5.341,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.7-6.637,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.6-4.5392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.91-0.0418,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.80.821,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.12-1.11
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.92-1.11
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.68-1.15
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.45-1.077,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.61-5.27
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.06-5.3
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.3-5.3
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.751.37392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.48-2.1919,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.2-2.85Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.83-0.127,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.08-0.54Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.92.05Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.921.61Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.322.29Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.2-0.23Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.55-3.75Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.255.93Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.798.87Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.326.63Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.326.63Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.41.09Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.38-0.5Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.783.35Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.123.35Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.082.66Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.441.77Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.060.82Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.70.82Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9210.73Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2110.73Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3511.3Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5115.06Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0815.06Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244416.67Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.222.46Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.222.46Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8722.98Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.619.19Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6517.04Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6814.05Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.215.32Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.614.4Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514048Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.143.57Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.441.76Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.9527985.66Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.7871.52Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.474.18Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.5372.55Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.1574.88Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.9274.88Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.6479.11Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.1379.11Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.0780.24Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.7380.24Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.8178.37Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.378.37Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.9472.78Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.6172.78Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.5671.86Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.4274.41Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.7674.41Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.572.67Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.276.07Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.5877.28Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.2377.28Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.2875.59Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2102.19Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.4198.47Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.1528383.04Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.0484.34Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2464.13Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6863.2Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.265.92Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.866.99Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.453.53Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.553.25Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1453.44Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538933.16Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338634.2Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4833.57Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3233.16Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7930.61Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1551.91Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7951.91Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.650.32Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7847.92Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5252.26Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9452.26Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3451.11Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2550.14Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8748.25Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.628.73Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9527.02Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8426.84Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8827.96Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7827.84Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.234.83Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3329.24Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8829.56Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5829.5Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2525.42Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.126.84Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9225.36Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179822.34Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6522.57Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6524.94Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0425.3Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1428.73Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8524.7Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7429.63Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2729.63Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6829.63Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9129.63Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6532.62Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010029.5Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4432.89Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8832.82Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.832.89Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8832.89Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0433.37Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1732.96Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1161.77
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1161.77
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6241.76
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8946.41
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199536.32
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9144.13
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6244.13
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8144.13
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4544.13
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.628.73
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5233.09
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7232.48
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.132.48
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4632.48
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8232.48
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2831.34
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.641.69
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.972.49
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.833.51
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5535.39
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.620.35
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3625.73
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3625.73
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.224.22
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8533.44
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0228.41
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1134.55
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1134.55
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.840.76
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9830.35
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9830.35
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.629.18
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.728.41
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3227.21
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.415.06
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3514.25
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4818.86
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6512.95
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0314.15
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.089.42
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.246066.85
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.129.01
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125223.33
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1534.48
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20229.5
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0430.02
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7730.09
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4630.09
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0530.09
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2843.97
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522538.13
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.234.41
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6450.41
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0837.47
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.826.46
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1528.03
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2214.7
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1212.56
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1912.9
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.481.41
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8914.3
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9312.12
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4117.73
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8412.27
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4411.59
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9228.47
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8430.54
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2831.54
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.431.47
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5932.35
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3738.06
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9230.09
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9933.23
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1622.29
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018836.24
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9235.18
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2947.49
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8958.7
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8758.7
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.158.7
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0958.7
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7756.12
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6656.12
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.956.12
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6256.12
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9567.1
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6167.1
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0267.1
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.667.1
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8467.1
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9567.1
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4455.84
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.558.8
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2449.97
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4350.93
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1541.68
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8741.68
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.341.68
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2841.68
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2641.68
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.241.14
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1543.17
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8843.17
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.443.09
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0943.17
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4143.17
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1642.46
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2631.94
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1439.7
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.239.7
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7339.7
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0439.7
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0439.7
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5741.92
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5641.92
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0441.92
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6741.92
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5541.92
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4442.94
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8136.53
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8520.02
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4520.02
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1720.02
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0720.02
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.717.89
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3825.73
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8825.73
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1325.73
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2625.73
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.7284.34Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.2184.34Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.1784.34Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79115.83Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21115.83Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK